Holen Sie sich die Stockscreener-App
1.11
0.89%
-0.01
Handel nachbörslich:
1.12
0.01
+0.90%
Boundless Bio Inc Aktie (BOLD) Neueste Nachrichten
Leerink reiterates Market Perform on Boundless Bio stock at $4 - Investing.com
Boundless Bio (BOLD) Posts First Revenue of $17.3M, Narrows Q4 Loss to $0.58/Share - AlphaStreet
Boundless Bio Reports Q4 and Full Year 2025 Financial Results, Highlights Progress of KOMODO-1 Clinical Trial and BBI-940 Program - Minichart
Bold Biosciences 2025 10-K: ecDNA-Enabled Cancer Drug Development, Spyglass Platform & BBI-940 Kinesin Degrader Overview - Minichart
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - Bitget
Boundless Bio beats fourth quarter loss estimates By Investing.com - Investing.com Canada
Boundless Bio 10-K: $0 Revenue, $(58.2)M Net Loss, $(63.6)M Operating Loss - TradingView
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - GlobeNewswire Inc.
Exit Recap: Is Boundless Bio Inc stock a smart retirement pickEarnings Summary Report & AI Enhanced Trading Signals - baoquankhu1.vn
Breakouts Watch: Can MSPRI sustain its profitabilityMarket Performance Summary & Low Drawdown Momentum Ideas - baoquankhu1.vn
Boundless Bio to Participate in the Leerink Global Healthcare Conference - The Manila Times
Rezolute to Participate in the Citizens Life Sciences Conference - Bitget
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight – Company AnnouncementFT.com - Financial Times
BOLD Should I Buy - Intellectia AI
BOLD SEC FilingsBOUNDLESS BIO INC 10-K, 10-Q, 8-K Forms - Stock Titan
MDCX PE Ratio & Valuation, Is MDCX Overvalued - Intellectia AI
Signal Recap: How liquid is AMBIWS stock2025 Retail Activity & AI Enhanced Trading Alerts - baoquankhu1.vn
Volume Recap: Can Broadstone Net Lease Inc outperform under higher oil prices2025 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn
Nextech exits Boundless Bio (NASDAQ: BOLD) with reported 0% ownership - Stock Titan
Will Boundless Bio Inc. stock continue dividend increasesInflation Watch & Consistent Income Trade Recommendations - mfd.ru
What Makes CTS (CTS) a New Buy Stock - Bitget
What Makes KB Financial (KB) a Strong Momentum Stock: Buy Now? - Bitget
Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's Why - Yahoo Finance
Boundless Bio Advances New Breast Cancer Drug BBI-940 Into First-in-Human Trial - TipRanks
FMR LLC Reduces Stake in Boundless Bio Inc: A Strategic Portfoli - GuruFocus
What is the long term forecast for Boundless Bio Inc. stockJuly 2025 Analyst Calls & Weekly High Conviction Ideas - mfd.ru
Investment Recap: What are the analyst revisions for Boundless Bio IncIs RAAQU stock a good investment in YEARJuly 2025 Chart Watch & Fast Exit Strategy with Risk Control - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Fed Watch: Does Boundless Bio Inc have pricing powerWall Street Watch & Momentum Based Trading Signals - baoquankhu1.vn
Finance Watch: Four IPOs In One Week - Citeline News & Insights
Fund Flows: Can Boundless Bio Inc weather a recession2025 Investor Takeaways & AI Forecast Swing Trade Picks - baoquankhu1.vn
Boundless Bio CEO Zachary Hornby to Speak at Guggenheim Emerging Outlook: Biotech Summit 2026 - Quiver Quantitative
Cancer biotech Boundless Bio preps Guggenheim fireside chat with online webcast - Stock Titan
Is Boundless Bio (NASDAQ:BOLD) In A Good Position To Invest In Growth? - simplywall.st
Patterns Watch: Is Boundless Bio Inc subject to activist investor interestQuarterly Trade Review & Risk Managed Investment Strategies - baoquankhu1.vn
We're Keeping An Eye On Boundless Bio's (NASDAQ:BOLD) Cash Burn Rate - Yahoo Finance
Layoff Tracker: Gilead Continues California Cuts With 34 Laid Off - BioSpace
Is Boundless Bio Inc. stock a good pick for beginnersJuly 2025 Short Interest & AI Driven Price Predictions - mfd.ru
Boundless Bio (BOLD) awards 140,000-share stock option to finance chief - Stock Titan
Day Trade: How does HSIC compare to its peers2025 Key Lessons & Capital Efficiency Focused Ideas - baoquankhu1.vn
Update Report: Is Alamos Gold Inc forming bullish engulfing patterns2025 Price Momentum & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Short Squeeze: Is Toppoint Holdings Inc a speculative investmentJuly 2025 WrapUp & Consistent Profit Trade Alerts - baoquankhu1.vn
Aug Drivers: Can MBNKP continue delivering strong returnsWeekly Trade Analysis & Smart Investment Allocation Insights - baoquankhu1.vn
VIX Spike: Is PHVS forming a bullish divergenceJuly 2025 Weekly Recap & Technical Pattern Based Signals - baoquankhu1.vn
Boundless Bio’s kinesin degrader gains IND approval - BioWorld MedTech
FDA accepts Boundless Bio’s IND for novel cancer drug BBI-940 - Investing.com Canada
Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 And Extends Cash Runway - TradingView
Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway - marketscreener.com
Boundless Bio halts trial to back new breast cancer drug to 2028 - Stock Titan
Can Boundless Bio Inc. stock withstand economic slowdownMarket Activity Recap & AI Driven Price Predictions - bollywoodhelpline.com
What is POLA’s market positionRecession Risk & Daily Technical Forecast Reports - bollywoodhelpline.com
Trump's Policies Stir Crypto Market Uncertainty - Intellectia AI
Earnings Report: Will ACRPRC stock go up in YEAR2025 Dividend Review & AI Driven Stock Price Forecasts - baoquankhu1.vn
How First Trust EIP Power Solutions stock reacts to monetary easingQuarterly Trade Summary & Low Risk Investment Opportunities - Bollywood Helpline
Sentiment Watch: Does G III Apparel Group Ltd stock benefit from AI growthMarket Growth Summary & Reliable Entry Point Alerts - baoquankhu1.vn
Winners Losers: Is ZNTL forming a bullish divergence2025 Market Sentiment & Growth-Oriented Investment Plans - baoquankhu1.vn
Sectors Review: Whats the fair value of POWPRB stockJuly 2025 Sector Moves & Low Risk High Win Rate Picks - baoquankhu1.vn
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):